Your browser doesn't support javascript.
loading
Antibody Mediated Rejection and T-cell Mediated Rejection Molecular Signatures Using Next-Generation Sequencing in Kidney Transplant Biopsies.
Cortes Garcia, Esteban; Giarraputo, Alessia; Racapé, Maud; Goutaudier, Valentin; Ursule-Dufait, Cindy; de la Grange, Pierre; Adoux, Lucie; Raynaud, Marc; Couderau, Clément; Mezine, Fariza; Dagobert, Jessie; Bestard, Oriol; Moreso, Francesc; Villard, Jean; Halleck, Fabian; Giral, Magali; Brouard, Sophie; Danger, Richard; Gourraud, Pierre-Antoine; Rabant, Marion; Couzi, Lionel; Le Quintrec, Moglie; Kamar, Nassim; Morelon, Emmanuel; Vrtovsnik, François; Taupin, Jean-Luc; Snanoudj, Renaud; Legendre, Christophe; Anglicheau, Dany; Budde, Klemens; Lefaucheur, Carmen; Loupy, Alexandre; Aubert, Olivier.
  • Cortes Garcia E; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
  • Giarraputo A; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
  • Racapé M; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
  • Goutaudier V; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
  • Ursule-Dufait C; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
  • de la Grange P; GenoSplice, Paris, France.
  • Adoux L; Université Paris Cité, Centre National de la Recherche Scientifique (CNRS), INSERM, Institut Cochin, Paris, France.
  • Raynaud M; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
  • Couderau C; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
  • Mezine F; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
  • Dagobert J; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
  • Bestard O; Department of Nephrology and Kidney Transplantation, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Moreso F; Department of Nephrology and Kidney Transplantation, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Villard J; Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals, Geneva, Switzerland.
  • Halleck F; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Giral M; Nantes Université, INSERM, CRT2I-Center for Research in Transplantation and Translational Immunology, Nantes, France.
  • Brouard S; Nantes Université, INSERM, CRT2I-Center for Research in Transplantation and Translational Immunology, Nantes, France.
  • Danger R; Nantes Université, INSERM, CRT2I-Center for Research in Transplantation and Translational Immunology, Nantes, France.
  • Gourraud PA; Nantes Université, Centre Hospitalier Universitaire de Nantes, Pôle Hospitalo-Universitaire 11: Santé Publique, Clinique des données, INSERM, Centre d'Investigation Clinique 1413, Nantes, France.
  • Rabant M; Department of Pathology, Necker-Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris, Université Paris Cité, Paris, France.
  • Couzi L; Centre Hospitalier Universitaire de Bordeaux, Service de Néphrologie, Transplantation, Dialyse et Aphérèses, Bordeaux, France.
  • Le Quintrec M; Department of Nephrology Dialysis and Kidney Transplantation, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
  • Kamar N; Department of Nephrology and Organ Transplantation, Toulouse Rangueil University Hospital, INSERM UMR 1291, Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), University Paul Sabatier, Toulouse, France.
  • Morelon E; Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon, Lyon, France.
  • Vrtovsnik F; Department of Kidney Transplantation, Bichat Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • Taupin JL; Laboratory of Immunology and Histocompatibility, Hôpital Saint-Louis Assistance Publique - Hôpitaux de Paris, Paris, France.
  • Snanoudj R; Assistance Publique des Hôpitaux de Paris (AP-HP), Université Paris-Saclay, Hôpital de Bicêtre, Service de Néphrologie et Transplantation, Le Kremlin-Bicêtre, France.
  • Legendre C; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
  • Anglicheau D; Department of Kidney Transplantation, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Budde K; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
  • Lefaucheur C; Department of Kidney Transplantation, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Loupy A; Department of Nephrology and Intensive Care, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Aubert O; Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
Transpl Int ; 37: 13043, 2024.
Article en En | MEDLINE | ID: mdl-39050190
ABSTRACT
Recently, interest in transcriptomic assessment of kidney biopsies has been growing. This study investigates the use of NGS to identify gene expression changes and analyse the pathways involved in rejection. An Illumina bulk RNA sequencing on the polyadenylated RNA of 770 kidney biopsies was conducted. Differentially-expressed genes (DEGs) were determined for AMR and TCMR using DESeq2. Genes were segregated according to their previous descriptions in known panels (microarray or the Banff Human Organ Transplant (B-HOT) panel) to obtain NGS-specific genes. Pathway enrichment analysis was performed using the Reactome and Kyoto Encyclopaedia of Genes and Genomes (KEGG) public repositories. The differential gene expression using NGS analysis identified 6,141 and 8,478 transcripts associated with AMR and TCMR. While most of the genes identified were included in the microarray and the B-HOT panels, NGS analysis identified 603 (9.8%) and 1,186 (14%) new specific genes. Pathways analysis showed that the B-HOT panel was associated with the main immunological processes involved during AMR and TCMR. The microarrays specifically integrated metabolic functions and cell cycle progression processes. Novel NGS-specific based transcripts associated with AMR and TCMR were discovered, which might represent a novel source of targets for drug designing and repurposing.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Trasplante de Riñón / Secuenciación de Nucleótidos de Alto Rendimiento / Rechazo de Injerto Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos T / Trasplante de Riñón / Secuenciación de Nucleótidos de Alto Rendimiento / Rechazo de Injerto Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2024 Tipo del documento: Article